| 1 |
Osum M, Kalkan R. Cancer Stem Cells and Their Therapeutic Usage. Adv Exp Med Biol 2023. [PMID: 36689167 DOI: 10.1007/5584_2022_758] [Reference Citation Analysis]
|
| 2 |
Zhu M, Li S, Cao X, Rashid K, Liu T. The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment. Semin Cancer Biol 2023;88:18-31. [PMID: 36410636 DOI: 10.1016/j.semcancer.2022.11.011] [Reference Citation Analysis]
|
| 3 |
An J, Hu X, Liu F. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies. Front Oncol 2023;13:1114621. [PMID: 36910604 DOI: 10.3389/fonc.2023.1114621] [Reference Citation Analysis]
|
| 4 |
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, Zhaoshen Li, Jie Gao. Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison. Bioact Mater 2022;22. [PMID: 36330160 DOI: 10.1016/j.bioactmat.2022.10.016] [Reference Citation Analysis]
|
| 5 |
Didamson OC, Chandran R, Abrahamse H. A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells. Cancers 2022;14:4558. [DOI: 10.3390/cancers14194558] [Reference Citation Analysis]
|
| 6 |
Telang NT. Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery. IJMS 2022;23:9223. [DOI: 10.3390/ijms23169223] [Reference Citation Analysis]
|
| 7 |
Kim R, Kawai A, Wakisaka M, Shimoyama M, Yasuda N, Kin T, Arihiro K. Breast cancer recurrence and survival rates in patients who underwent breast-conserving surgery under non-mechanically ventilated anesthesia. Cancer Rep (Hoboken) 2023;6:e1643. [PMID: 35655440 DOI: 10.1002/cnr2.1643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
钱 丽. Changes in the Microenvironment after HPV Infection. ACM 2022;12:3448-3453. [DOI: 10.12677/acm.2022.124499] [Reference Citation Analysis]
|
| 9 |
Tai Y, Ma Y, Chen C, Tsai H, Tsai C, Wu M, Chen C, Lin M. Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway. CIMB 2022;44:63-72. [DOI: 10.3390/cimb44010005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
